Mina C. Hosseinipour
University of North Carolina at Chapel Hill
378 Papers
1.7K Citations
Mina C. Hosseinipour is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 48, co-authored 333 publications. Previous affiliations of Mina C. Hosseinipour include University of Malawi & Kamuzu Central Hospital.
Chat about Author
Papers
Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi.
Derek C. Johnson,Charles Chasela,Madalitso Maliwichi,Albert Mwafongo,Adesola Akinkuotu,Agness Moses,Denise J. Jamieson,Athena P. Kourtis,Caroline C. King,Charles van der Horst,Mina C. Hosseinipour +10 more
TL;DR: The findings indicate few patients would be excluded from a TDF-based antiretroviral regimen, suggesting baseline creatinine clearance assessment may not be necessary for implementation, however, in ART settings individuals with low BMI or anemia could potentially be at increased risk for lower CrCl.
Family Planning Providers' Experiences and Perceptions of Long-Acting Reversible Contraception in Lilongwe, Malawi.
Tapika Mwafulirwa,Michele S. O’Shea,Gloria Hamela,Emilia Samuel,Christine Chingondole,Virginia Chipangula,Mina C. Hosseinipour,Jennifer H. Tang +7 more
TL;DR: In this article, the authors conducted a mixed-methods study using questionnaires and focus group discussions with providers in Lilongwe, and found that less than 2% of Malawian women use long-acting reversible contraception (LARC).
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
Jessica M. Fogel,Sarah E. Hudelson,San San Ou,Stephen Hart,Carole L. Wallis,Mariza G. Morgado,Shanmugam Saravanan,Srikanth Tripathy,Laura Hovind,Estelle Piwowar-Manning,Devin Sabin,Marybeth McCauley,Theresa Gamble,Xinyi C. Zhang,Joseph J. Eron,Joel E. Gallant,Johnstone Kumwenda,Joseph Makhema,Nagalingeswaran Kumarasamy,Suwat Chariyalertsak,James Hakim,Sharlaa Badal-Faesen,Victor Akelo,Mina C. Hosseinipour,Breno Santos,Sheela Godbole,José Henrique Pilotto,Beatriz Grinsztejn,Ravindre Panchia,Kenneth H. Mayer,Kenneth H. Mayer,Ying Q. Chen,Myron S. Cohen,Susan H. Eshleman +33 more
TL;DR: Early initiation of antiretroviral treatment (ART) reduces HIV transmission and has health benefits and high baseline viral load and less education were associated with emergence of resistance at ART failure.
Second assessment of NeuroAIDS in Africa
Kevin Robertson,Kathy L. Kopnisky,James Hakim,Concepta Merry,Noeline Nakasujja,Colin D. Hall,Moussa Traore,Ned Sacktor,David B. Clifford,Charles R. Newton,Annelies Van Rie,Penny Holding,Penny Holding,Janice E. Clements,Christine Zink,Jens Mielke,Mina C. Hosseinipour,Umesh G. Lalloo,Farida Amod,Christina M. Marra,Scott R. Evans,Jeff Liner +21 more
TL;DR: The conference presentations summarized here highlight the need for further research on neuroAIDS in Africa and methods for assessing HIV-related neurological disorders.
Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi:
TL;DR: In this article, the authors explored the geographic and individual factors associated with starting ART on time in Malawi and found that patients who were eligible for ART based on a CD4 cell count <250 cells/mm3 versus WHO stage were less likely to start ART at both LH and MPC.
15